M. Dose

2.2k total citations
48 papers, 1.2k citations indexed

About

M. Dose is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, M. Dose has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 13 papers in Cellular and Molecular Neuroscience and 11 papers in Neurology. Recurrent topics in M. Dose's work include Schizophrenia research and treatment (15 papers), Genetic Neurodegenerative Diseases (11 papers) and Bipolar Disorder and Treatment (10 papers). M. Dose is often cited by papers focused on Schizophrenia research and treatment (15 papers), Genetic Neurodegenerative Diseases (11 papers) and Bipolar Disorder and Treatment (10 papers). M. Dose collaborates with scholars based in Germany, Austria and Switzerland. M. Dose's co-authors include H. M. Emrich, D. von Zerssen, Kurt Hahlweg, Hinderk M. Emrich, J.‐C. Krieg, Michael H. Wiegand, Wolfgang Schreiber, Stephan Stolz, Alexander Yassouridis and Christoph Lauer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and The British Journal of Psychiatry.

In The Last Decade

M. Dose

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Dose Germany 19 572 337 215 214 213 48 1.2k
Philippe Baruch Canada 13 474 0.8× 355 1.1× 122 0.6× 221 1.0× 218 1.0× 26 1.1k
Jesús Ramírez‐Bermúdez Mexico 20 463 0.8× 341 1.0× 117 0.5× 284 1.3× 142 0.7× 101 1.4k
J.L. Waddington Ireland 20 1.1k 1.9× 455 1.4× 272 1.3× 224 1.0× 397 1.9× 31 1.8k
M.A. Reveley United Kingdom 20 878 1.5× 255 0.8× 190 0.9× 431 2.0× 120 0.6× 37 1.5k
Alonso Montoya Canada 19 678 1.2× 385 1.1× 329 1.5× 457 2.1× 174 0.8× 48 1.4k
Lawrence Adler United States 18 589 1.0× 193 0.6× 179 0.8× 298 1.4× 305 1.4× 30 1.3k
Ernst Franzek Germany 26 918 1.6× 560 1.7× 310 1.4× 468 2.2× 502 2.4× 83 2.2k
Rainer Wolf Germany 17 560 1.0× 302 0.9× 154 0.7× 179 0.8× 254 1.2× 40 1.4k
Daniel Alicata United States 16 285 0.5× 450 1.3× 135 0.6× 337 1.6× 184 0.9× 30 1.3k
Eugen Davids Germany 16 571 1.0× 376 1.1× 135 0.6× 283 1.3× 88 0.4× 36 927

Countries citing papers authored by M. Dose

Since Specialization
Citations

This map shows the geographic impact of M. Dose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dose more than expected).

Fields of papers citing papers by M. Dose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Dose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dose. The network helps show where M. Dose may publish in the future.

Co-authorship network of co-authors of M. Dose

This figure shows the co-authorship network connecting the top 25 collaborators of M. Dose. A scholar is included among the top collaborators of M. Dose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Dose. M. Dose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffmann, Rainer, et al.. (2024). Psychiatrische Symptome der Huntington-Krankheit. Der Nervenarzt. 95(9). 871–884. 1 indexed citations
3.
Saft, Carsten, Jean‐Marc Burgunder, M. Dose, et al.. (2023). Differential diagnosis of chorea (guidelines of the German Neurological Society). SHILAP Revista de lepidopterología. 5(1). 63–63. 4 indexed citations
4.
Kästner, Anne, Martin Begemann, Tanja Maria Michel, et al.. (2015). Autism beyond diagnostic categories: characterization of autistic phenotypes in schizophrenia. BMC Psychiatry. 15(1). 115–115. 76 indexed citations
5.
Dose, M.. (2014). Option einer ambulanten Zwangsbehandlung – Pro. Psychiatrische Praxis. 41(5). 239–240.
6.
Obertová, Zuzana, M. Dose, Peter Gabriel, et al.. (2013). The juvenile face as a suitable age indicator in child pornography cases: a pilot study on the reliability of automated and visual estimation approaches. International Journal of Legal Medicine. 128(5). 803–808. 24 indexed citations
7.
Dose, M.. (2009). Das Asperger-Syndrom. Fortschritte der Neurologie · Psychiatrie. 78(4). 233–244. 3 indexed citations
8.
Finke, Kathrin, Peter Bublak, M. Dose, Hermann J. Müller, & Werner X. Schneider. (2006). Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease. Brain. 129(5). 1137–1151. 53 indexed citations
9.
Kraus, P, et al.. (2004). The N-methyl-D-aspartate antagonist memantine retards progression of Huntington’s disease. Journal of neural transmission. Supplementum. 117–122. 76 indexed citations
10.
Grunze, Heinz, J. Walden, Sandra Dittmann, et al.. (2002). Psychopharmakotherapie bipolarer affektiver Erkrankungen. Der Nervenarzt. 73(1). 4–19. 14 indexed citations
11.
Dose, M., et al.. (2000). Abuse Potential of Anticholinergics. Pharmacopsychiatry. 33(Suppl 1). 43–46. 26 indexed citations
12.
Davidson, Michael, Philip D. Harvey, C. A. Gagiano, et al.. (2000). A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. International Journal of Geriatric Psychiatry. 15(6). 506–514. 79 indexed citations
13.
Dose, M.. (2000). Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes. Pharmacopsychiatry. 33(Suppl 1). 3–13. 34 indexed citations
14.
Dose, M., et al.. (1998). Combined Treatment of Schizophrenic Psychoses with Haloperidol and Valproate. Pharmacopsychiatry. 31(4). 122–125. 37 indexed citations
15.
Wiedemann, Georg, et al.. (1994). Deliverability of Psychoeducational Family Management. Schizophrenia Bulletin. 20(3). 547–556. 21 indexed citations
16.
Wiegand, Michael H., Christoph Lauer, Stephan Stolz, et al.. (1991). Nocturnal sleep in huntington's disease. Journal of Neurology. 238(4). 203–208. 114 indexed citations
17.
Hahlweg, Kurt, et al.. (1991). Cross-national reliability, concurrent validity, and stability of a brief method for assessing expressed emotion. Psychiatry Research. 39(1). 25–31. 74 indexed citations
18.
Dose, M. & H. M. Emrich. (1990). Combined treatment of schizophrenic psychoses with haloperidol and carbamazepine: Results of a controlled study and clinical experiences. International Clinical Psychopharmacology. 5. 35–42. 1 indexed citations
19.
Raptis, Constantine A., et al.. (1990). Anticonvulsants as adjuncts for the neuroleptic treatment of schizophrenic psychoses: a clinical study with beclamide. Acta Psychiatrica Scandinavica. 81(2). 162–167. 8 indexed citations
20.
Dose, M., et al.. (1987). Carbamazepine as an adjunct of antipsychotic therapy. Psychiatry Research. 22(4). 303–310. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026